Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LSS | P48449 | 10/20 | 0.66 |
| ▸ | THRB | P10828 | 1/20 | 0.56 |
| ▸ | ACHE | P22303 | 4/20 | 0.53 |
| ▸ | BCHE | P06276 | 3/20 | 0.53 |
| ▸ | LTA4H | P09960 | 2/20 | 0.51 |
| ▸ | PPARA | Q07869 | 2/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12795163 | 0.96 | LSS (0.65) | LSSTHRBACHEBCHELTA4H | |
| SCHEMBL11994238 | 0.89 | THRB (0.66) | LSSTHRBLTA4HPPARAGAA | |
| SCHEMBL22609158 | 0.89 | THRB (0.66) | LSSTHRBLTA4HPPARAGAA | |
| SCHEMBL13579151 | 0.88 | BCHE (0.59) | LSSTHRBACHEBCHEPPARA | |
| SCHEMBL15525736 | 0.87 | THRB (0.64) | LSSTHRBLTA4HPPARAGAA | |
| SCHEMBL12795140 | 0.86 | LSS (0.56) | LSSTHRBACHEBCHELTA4H | |
| SCHEMBL7647944 | 0.86 | ACHE (0.53) | LSSACHEBCHEGAA | |
| SCHEMBL12795159 | 0.85 | BCHE (0.58) | LSSTHRBACHEBCHE | |
| SCHEMBL899301 | 0.85 | THRB (0.77) | LSSTHRBLTA4HPPARAGAA | |
| SCHEMBL12795150 | 0.84 | LSS (0.53) | LSSTHRBACHEBCHEPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2130817-B1 | Polymerizable Type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2016-01-06 | — | — | EP | disclosed |
| US-8389769-B2 | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-03-05 | — | — | US | disclosed |
| US-8389769-B2 | Polymerizable type II photoinitiators and curable compositions | AGFA GRAPHICS NV (BE) | 2013-03-05 | — | — | US | disclosed |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-17 | — | — | US | disclosed |
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | AGFA GRAPHICS NV (BE) | 2011-03-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110063388-A1 | POLYMERIZABLE TYPE II PHOTOINITIATORS AND CURABLE COMPOSITIONS | CCNH, CRKL, ERH | LSS 1831/4885THRB 3119/4885ACHE 3603/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.